PubMed Health⌕ Search

Biomedical subjects

K P Gunaga

Publications and source records attributed to K P Gunaga.

At least 19 recordsLinked to original sources

Apolipoproteins in obesity: effect of weight loss.

We evaluated serum concentrations of apoprotein (APO) A1, B, total cholesterol, triglycerides, high density cholesterol (HDL-C), and low density cholesterol (LDL-C) in twelve obese subjects whose body mass index (BMI) was > or = 30 before and after a clinically significant weight loss was obtained utilizing a very-low calorie diet (VLCD) consisting of liquid protein (Optifast) providing 800 calories a day. At baseline, the mean weight +/- SD was 119.77 Kg and decreased significantly to 89.29 +/- 13.46 Kg by 24 weeks. Statistically significant reductions of APO-A1, APO-B, total cholesterol, and triglyceride concentrations were also observed along with the weight loss. LDL-C decreased from 156.0 +/- 55.9 mg/dL to 122.5 +/- 42.2 mg/dL (4.03 +/- 1.4 to 3.16 +/- 1.1 mmol/L), but this difference was not statistically significant. There was no significant change in the HDL-C and the ratios of APO-A1 to APO-B. We conclude that the use of VLCD is associated with changes in the lipid pattern that lower the cardiovascular risk profile in addition to the beneficial effects of weight loss itself.

Adult↗

Utility of micral test strips in screening for microalbuminuria.

OBJECTIVE: To evaluate the clinical utility of Micral strips for detection of microalbuminuria. DESIGN: One hundred three urine samples were tested by Micral strips for the presence of microalbuminuria, and the results were compared with the immunonephelometric method. SETTING: Endocrine diabetes clinic in a university-affiliated outpatient facility and the associated clinical laboratory. PATIENTS: Sixty-seven, 24-hour urine samples were obtained from 64 patients with diabetes. Thirty-six urine samples were obtained from normal controls; 22 of these were 24-hour samples and 14 were overnight samples. MAIN OUTCOME MEASURE: Concordance of results obtained by the two methods for the presence or absence of microalbuminuria. RESULTS: All 36 control subjects and 44 urine samples from diabetic patients had normal albumin excretion (<15 mg/24 h) by the immunonephelometric method. Seventy-eight of these were correctly identified as negative by Micral strips, giving a specificity of 97.5%. There were 23 samples with albumin excretion of more than 16 mg/24 h. Sixteen of these were correctly identified, giving a sensitivity of 69.5%. There were 16 samples with albumin excretion of 30 mg/24 h or more; 14 of these were correctly identified by Micral strips, and two were false negatives, giving a sensitivity of 87.7%. However, when urine samples with albumin concentrations of less than 11 mg/L were excluded, the Micral strips correctly read 21 out of 23 samples, giving a sensitivity of 91.3%. CONCLUSIONS: The specificity of Micral strips for detection of albuminuria in 24-hour urine samples is high (97.5%), but the sensitivity is low, ranging from 69.5% to 87.7%. The sensitivity was greatly improved when urine samples with albumin concentrations of less than 11 mg/L were excluded.

Albuminuria↗

Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.

Monocrotaline pyrrole (MCTP), a putative, toxic metabolite of monocrotaline, induces delayed and progressive lung injury, vascular remodeling, and pulmonary hypertension in rats. The lung injury is characterized by increased wet lung-to-body weight ratio followed by increases in lactate dehydrogenase (LDH) activity and protein concentration in the cell-free bronchoalveolar lavage fluid (BALF) and increased cellularity of BALF. We evaluated total LDH activity and isozyme patterns in the tissues, cell lysates, sera and cell-free BALF of rats after treatment with MCTP to determine the source of increased LDH activity. Male Sprague-Dawley rats were given a single injection of MCTP (3.5 mg/kg) or an equal volume of the N,N-dimethylformamide (DMF) vehicle in the tail vein on Day 0. Rats were killed at 4, 8, or 14 days after toxicant administration, and several markers of lung injury, LDH activity, and isozyme patterns of various tissues, cells, and body fluids were determined. At 8 and 14 days, the lungs from MCTP-treated rats had multifocal, irregularly shaped lesions of hemorrhage and consolidation. At Day 14 only, the hearts of MCTP-treated rats appeared enlarged and there was right cardioventricular hypertrophy. Rats treated with MCTP had no macroscopic lesions in kidneys, liver, or skeletal muscle. Compared to controls, MCTP-treated animals had no change in total LDH activity or isozyme patterns of samples of lungs, heart, skeletal muscle, liver, kidneys, or erythrocyte lysates. Changes in LDH activity in the cell-free BALF and BALF cell pellet from rats treated with MCTP were characterized by increases in isozymes LDH4 and LDH5 and an elevated LDH4/LDH5 ratio in the BALF only. Our results suggest the most probable source of the increased LDH activity in cell-free BALF of MCTP-treated rats originates from the lung tissue and is consistent with a contribution from the pulmonary vascular endothelium, a source rich in LDH4. A combination of plasma, macrophages, and neutrophils in the pulmonary tissue may also have made minor contributions to the increase in cell-free BALF LDH activity, particularly to the activity of LDH5.

Animals↗

GnRH action in rat anterior pituitary gland: regulation of protein, glycoprotein and LH synthesis.

The effect of synthetic GnRH on the synthesis of proteins and glycoproteins in the anterior pituitary and in vitro release of LH into the medium was studied. A maximal dose (25 ng/ml) of of synthetic GnRH caused optimum release of radioimmunoassayable LH into the medium after 2 h of incubation. A concomitant increase in cyclic AMP accumulation in the tissue and LH in the incubation medium was also observed under the influence of GnRH during different periods of incubation time. Incubation of the rat anterior pituitary with GnRH stimulated the incorporation of [3H] proline into acid precipitable proteins in a time- and dose-dependent manner, similar to radioimmunoassayable LH released into the medium. Similar results were obtained when pituitary was incubated with dibutyryl cyclic AMP. LH, in addition, enhanced the incorporation of [3H] glucosamine and [3H] amino acids mixture into acid-precipitable proteins suggesting that proteins including glycoproteins are synthesized by the rat anterior pituitary under the influence of GnRH. Approximately 10% of the radioactivity associated with proteins comigrated with radioimmunoassayable LH on the gels. GnRH also enhanced the incorporation of [3H] glucosamine and [3H] amino acid mixture into immunoprecipitable LH. The GnRH-induced incorporation of [3H] proline into anterior pituitary proteins was abolished by specific translation inhibitors.

Amino Acids↗

Cytoplasmic and nuclear receptor-estradiol complex in the hipothalamus and pituitary: relationship with pituitary sensitivity to gonadotropin releasing hormone and gonadotropin secretion in the rat.

S.c. introduction of silastic capsules containing estradiol-17beta (E2) in the ovariectomized rat causes a surge of luteinizing hormone (LH) on the following day. The levels of cytoplasmic and nuclear E2 receptor complex were measured in the pituitary and hypothalamus at 0, 9, 24 and 33 h intervals after placing the E2 implant. The pituitary sensitivity to exogenous gonadotropin releasing hormone (GnRH) with respect to LH release in vitro was also measured. The results suggest that: (1) the pituitary sensitivity to exogenous GnRH remained higher 9, 24, and 33 h after placing the implant; (2) the circulating LH level decreased at 24 h and then increased at 33 h; (3) the pituitary and hypothalamic E2 receptor levels show striking differences during E2-induced LH release. Thus, the relationship between pituitary sensitivity to exogenous GnRH and the E2 receptor level in the pituitary and hypothalamus is complex.

Animals↗

Stimulatory effect of gonadotropins on the synthesis of adenosine 3': 5'-cyclic monophosphate and progesterone by suspensions of rat ovarian interstitial cells.

A cell suspension was prepared from immature rat ovaries by treatment with trypsin and collagenase. The isolated cells were capable of converting [8-14-C]adenine to cyclic [-14-C]AMP and the rate of this conversion was stimulated in vitro by luteinizing hormone and human chorionic gonadotropine, but not by prolactin, norepinephrine, dopamine or albumin. The accumulation of progesterone was also measured in these cells by radioimmunoassay. In vitro addition of luteinizing hormone and human chorionic gonadotropine, but not by prolactin, norepinephrine, dopamine or albumin. The accumulation of progesterone was also measured in these cells by radioimmunoassay. In vitro addition of luteinizing hormone stimulated the accumulation of radioimmuno-assayable progesterone. The conversion of [8-14-C]adenine to cyclic [-14-C]AMP showed a rapid increase during the first 30 min of the incubation period when luteinizing hormone was added to the incubation medium. Progesterone accumulation in response to the same dose of luteinizing hormone showed a lag period for the first 30 min of incubation after which there was an increase up to 2 h. The luteinizing hormone-induced progesterone accumulation was sensitive to puromycin, but there was no effect on the luteinizing hormone-induced increase in cyclic [-14-C]AMP formation from [8-14-C]-adenine. Actinomycin D also inhibited the luteinizing hormone-induced progesterone accumulation in rat ovarian interstitial cell suspension is preceded by an increased accumulation of cyclic AMP and that the accumulation of steroid under the influence of luteinizing hormone involve processes sensitive to puromycin and antinomycin D.

Adenine↗